Sign in
4

Changes in Ownership

Lipocine Inc. Filed Acc 0001493152-25-000121

Options or other derivatives

  • Chief Executive Officer acquired 16,371 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Mahesh V. Chief Executive Officer 2025-01-02 Grant or award · Stock Option (Right to Buy) +16,371 $4.86 $79,563 149,039 D
Loading xslF345X05/ownership.xml…